Recommendations to Inform Substance Use Disorder Data Sharing Research: Scoping Review and Thematic Analysis
Overview
Authors
Affiliations
Objectives: Title 42 Code of Federal Regulations Part 2 (42 CFR Part 2 or Part 2) was enacted in 1975 to protect patients receiving treatment for substance use disorders. A scoping review on Part 2 characterized published work.
Methods: Seven databases were searched. Studies were categorized based on date of publication, primary objectives, methods, and findings. A thematic analysis was conducted using article titles and abstracts.
Results: Of the 36 studies identified, the majority (78%) were opinions or legal reviews, (22%) employed quantitative and/or qualitative methods to study the impact of Part 2, and over half (58%) were published in the past 5 years. Only 8% of studies reported stakeholder involvement in Part 2 studies and no study included patients or patient advocates. No study discussed the efforts to align Part 2 with Health Insurance Portability and Accountability Act or provided evidence of the benefit of this alignment. Three main themes emerged from the review: care delivery (46.6%), law and ethics (27.6%), and technology (25.9%). There were no studies focusing on stigma and its effect on substance use treatment and Part 2.
Conclusions: Despite the significance of Part 2, the literature is sparse. It is time to initiate a new era of scholarly research that focuses on the impact of statutes and policies that govern substance use disorder data sharing. Specifically, we recommend research on Part 2 and Health Insurance Portability and Accountability Act alignment, the effects of Part 2 on patients, as well as providers and other stakeholder perceptions on the regulation.
FHIR Granular Sensitive Data Segmentation.
Lee P, Mendoza D, Kaiser M, Lott E, Singh G, Grando A Appl Clin Inform. 2025; 16(1):156-166.
PMID: 39970944 PMC: 11839247. DOI: 10.1055/a-2466-4371.
Telemedicine-delivered treatment for substance use disorder: A scoping review.
Pham H, Lin C, Zhu Y, Clingan S, Lin L, Mooney L J Telemed Telecare. 2023; :1357633X231190945.
PMID: 37537907 PMC: 11444076. DOI: 10.1177/1357633X231190945.
Ivanova J, Saks M, Karway G, Murcko A, Espino C, Millea C Perspect Health Inf Manag. 2022; 19(Spring):1b.
PMID: 35692851 PMC: 9123523.